Milnacipran hydrochloride.
出版信息
Aust Prescr. 2017 Dec;40(6):244-245. doi: 10.18773/austprescr.2017.078. Epub 2017 Oct 23.
Abstract
摘要
相似文献
1
Milnacipran hydrochloride.盐酸米那普明
Aust Prescr. 2017 Dec;40(6):244-245. doi: 10.18773/austprescr.2017.078. Epub 2017 Oct 23.
2
Piloerection induced by replacing fluvoxamine with milnacipran.用米氮平替代氟伏沙明引起的竖毛反应。
Br J Clin Pharmacol. 2007 Jun;63(6):665-71. doi: 10.1111/j.1365-2125.2006.02838.x. Epub 2007 Feb 23.
3
Comparative efficacy and tolerability of duloxetine, pregabalin, and milnacipran for the treatment of fibromyalgia: a Bayesian network meta-analysis of randomized controlled trials.度洛西汀、普瑞巴林和米那普明治疗纤维肌痛的疗效及耐受性比较：一项随机对照试验的贝叶斯网络荟萃分析
Rheumatol Int. 2016 May;36(5):663-72. doi: 10.1007/s00296-016-3468-5. Epub 2016 Mar 21.
4
A new sensitive approach for spectrofluorimetric assay of Milnacipran and Amisulpride in real plasma and pharmaceutical preparations via complexation with Eosin Y dye.一种新的灵敏荧光光谱法，通过与曙红 Y 染料络合，用于测定真实血浆和药物制剂中米那普仑和氨磺必利的含量。
Spectrochim Acta A Mol Biomol Spectrosc. 2019 May 5;214:399-406. doi: 10.1016/j.saa.2019.02.071. Epub 2019 Feb 18.
5
Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats.度洛西汀（一种强效且平衡的5-羟色胺-去甲肾上腺素再摄取抑制剂）在大鼠持续性疼痛模型中的疗效。
J Pharmacol Exp Ther. 2004 Nov;311(2):576-84. doi: 10.1124/jpet.104.070656. Epub 2004 Jul 13.
6
Clinical utility of milnacipran in comparison with other antidepressants.
Int Clin Psychopharmacol. 2002 Jun;17 Suppl 1:S43-50. doi: 10.1097/00004850-200206001-00006.
7
Subchronic milnacipran treatment increases basal extracellular noradrenaline concentrations in the medial prefrontal cortex of rats.亚慢性米那普明治疗可提高大鼠内侧前额叶皮质的基础细胞外去甲肾上腺素浓度。
Eur J Pharmacol. 2005 Sep 27;520(1-3):37-42. doi: 10.1016/j.ejphar.2005.08.004.
8
Pooling two controlled comparisons of milnacipran (F2207) and amitriptyline in endogenous inpatients. A new approach in dose ranging studies.对米那普明（F2207）与阿米替林在内源性住院患者中的两项对照比较进行汇总分析。剂量范围研究的一种新方法。
Int Clin Psychopharmacol. 1990 Jan;5(1):49-56. doi: 10.1097/00004850-199001000-00005.
9
Milnacipran: serotonin-noradrenaline reuptake inhibitor approved for fibromyalgia may be a useful antidepressant.米那普明：一种被批准用于治疗纤维肌痛的5-羟色胺-去甲肾上腺素再摄取抑制剂，可能是一种有效的抗抑郁药。
Australas Psychiatry. 2018 Oct;26(5):537-540. doi: 10.1177/1039856218794874. Epub 2018 Sep 10.
10
Monoamine uptake inhibition by plasma from healthy volunteers after single oral doses of the antidepressant milnacipran.单次口服抗抑郁药米那普明后健康志愿者血浆对单胺的摄取抑制作用。
Eur J Clin Pharmacol. 1989;37(3):235-8. doi: 10.1007/BF00679776.
本文引用的文献
1
Milnacipran for neuropathic pain and fibromyalgia in adults.米那普明用于治疗成人神经性疼痛和纤维肌痛。
Cochrane Database Syst Rev. 2012 Mar 14;3(3):CD008244. doi: 10.1002/14651858.CD008244.pub2.
2
Longterm therapeutic response to milnacipran treatment for fibromyalgia. A European 1-year extension study following a 3-month study.米拉昔布治疗纤维肌痛的长期治疗反应。3 个月研究后进行的为期 1 年的欧洲扩展研究。
J Rheumatol. 2011 Jul;38(7):1403-12. doi: 10.3899/jrheum.101025. Epub 2011 Apr 1.
3
Comparative efficacy and acceptability of amitriptyline, duloxetine and milnacipran in fibromyalgia syndrome: a systematic review with meta-analysis.比较阿米替林、度洛西汀和米那普仑治疗纤维肌痛综合征的疗效和可接受性：系统评价与荟萃分析。
Rheumatology (Oxford). 2011 Mar;50(3):532-43. doi: 10.1093/rheumatology/keq354. Epub 2010 Nov 14.
4
The efficacy and safety of milnacipran for treatment of fibromyalgia. a randomized, double-blind, placebo-controlled trial.米那普明治疗纤维肌痛的疗效和安全性。一项随机、双盲、安慰剂对照试验。
J Rheumatol. 2009 Feb;36(2):398-409. doi: 10.3899/jrheum.080734.
Zotero 插件